News
Latest news related to non-animal research
-
4 November 2025Boosting the AOP Framework with AI, First-ever NAM to be formally qualified by the FDA, InnoZell’s Animal-free quality control, Alternatives to animal-derived products, and more
NEWS, REPORTS & POSITION STATEMENTS 1. NC3Rs’ DRIVER recommendations for in vitro research Research funders like Wellcome Trust and Cancer Research UK (CRUK) are now encouraging the use of the reporting system RIVER – Reporting In Vitro Experiments Responsibly, for […]
Read more -
29 October 2025NAMs for DILI, HUMAIN Award winners, STEP4NAMS Call, Machine learning to distinguish Neuropsychiatric disorders, and more
NEWS, REPORTS & POSITION STATEMENTS 1. NAMs for drug-induced liver injury (DILI): Where are we now ? The U.S. FDA’s National Center for Toxicological Research (NCTR) has published a new review : “New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are […]
Read more -
22 October 2025Alternatives to animal testing are the future, NC3Rs report on NAMs infrastructures, FDA’s CDER Inventory for NAMs, QKARs for enhanced drug toxicity prediction, and more
NEWS, REPORTS & POSITION STATEMENTS 1. Nature commentary on NAMs : Alternatives to animal testing are the future A new commentary has been published in the high impact journal Nature entitled “Alternatives to animal testing are the future — it’s time that journals, […]
Read more -
16 October 2025Japan joining the NAMs momentum, BiMMoH database launch, Charles River and Toxys new collaboration, Immune-competent lung-on-a-chip and more
NEWS, REPORTS & POSITION STATEMENTS 1. Japan has joined the NAMs momentum The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has joined the New Approach Methodology (NAMs) momentum alongside the FDA with the publication of guidelines to use them in […]
Read more -
9 October 2025OECD : Guidance on omics, NAMs for DART, Biotech Act, 2026 MPS World Summit Call for abstract, Deciphering brain organoids and more
NEWS, REPORTS & POSITION STATEMENTS 1. OECD : Guidance on good practices and standardisation of omics data Omics technologies are increasingly being used in regulatory toxicology as part of New Approach Methodologies (NAMs). These applications include identifying molecular points of departure for […]
Read more
